Stock Track | Compass Pathways Plunges 5.28% After Reporting Larger-Than-Expected Q3 Loss

Stock Track11-05

Shares of Compass Pathways PLC (CMPS) plummeted 5.28% in Tuesday's trading session following the release of its third-quarter financial results. The clinical-stage mental health care company reported a larger-than-anticipated loss, disappointing investors and triggering a sell-off.

According to the earnings report, Compass Pathways posted a quarterly adjusted loss of $1.44 per share for the quarter ended September 30, significantly wider than the loss of $0.56 per share reported in the same quarter last year. This figure also surpassed the mean expectation of ten analysts, who had forecast a loss of $0.39 per share. The company's reported loss of $137.72 million for the quarter further underscored the financial challenges it faces.

Despite the negative financial results, Compass Pathways remains focused on advancing its research in mental health treatments. The company announced plans to speed up the launch of its depression drug, which could potentially offer a new avenue for growth. However, investors seemed more concerned with the immediate financial performance, leading to the sharp decline in stock price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153232989?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 09:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153232989","market":"sg","top_or_hot":-1,"title":"Stock Track | Compass Pathways Plunges 5.28% After Reporting Larger-Than-Expected Q3 Loss","media":"Stock Track","content":"<p>Shares of Compass Pathways PLC (CMPS) plummeted 5.28% in Tuesday's trading session following the release of its third-quarter financial results. The clinical-stage mental health care company reported a larger-than-anticipated loss, disappointing investors and triggering a sell-off.</p>\n\n<p>According to the earnings report, Compass Pathways posted a quarterly adjusted loss of $1.44 per share for the quarter ended September 30, significantly wider than the loss of $0.56 per share reported in the same quarter last year. This figure also surpassed the mean expectation of ten analysts, who had forecast a loss of $0.39 per share. The company's reported loss of $137.72 million for the quarter further underscored the financial challenges it faces.</p>\n\n<p>Despite the negative financial results, Compass Pathways remains focused on advancing its research in mental health treatments. The company announced plans to speed up the launch of its depression drug, which could potentially offer a new avenue for growth. However, investors seemed more concerned with the immediate financial performance, leading to the sharp decline in stock price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Compass Pathways Plunges 5.28% After Reporting Larger-Than-Expected Q3 Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Compass Pathways Plunges 5.28% After Reporting Larger-Than-Expected Q3 Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-05 09:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Compass Pathways PLC (CMPS) plummeted 5.28% in Tuesday's trading session following the release of its third-quarter financial results. The clinical-stage mental health care company reported a larger-than-anticipated loss, disappointing investors and triggering a sell-off.</p>\n\n<p>According to the earnings report, Compass Pathways posted a quarterly adjusted loss of $1.44 per share for the quarter ended September 30, significantly wider than the loss of $0.56 per share reported in the same quarter last year. This figure also surpassed the mean expectation of ten analysts, who had forecast a loss of $0.39 per share. The company's reported loss of $137.72 million for the quarter further underscored the financial challenges it faces.</p>\n\n<p>Despite the negative financial results, Compass Pathways remains focused on advancing its research in mental health treatments. The company announced plans to speed up the launch of its depression drug, which could potentially offer a new avenue for growth. However, investors seemed more concerned with the immediate financial performance, leading to the sharp decline in stock price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CMPS","symbol_name":"COMPASS Pathways plc","start_time":0,"source_url":"","article_id":"1153232989","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153232989","pubTimestamp":1762306135,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Compass Pathways PLC (CMPS) plummeted 5.28% in Tuesday's trading session following the release of its third-quarter financial results. The clinical-stage mental health care company reported...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CMPS":"COMPASS Pathways plc"},"translate_title":"个股追踪|Compass Pathways公布第三季度亏损超预期后暴跌5.28%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CMPS":1},"content_text":"Shares of Compass Pathways PLC (CMPS) plummeted 5.28% in Tuesday's trading session following the release of its third-quarter financial results. The clinical-stage mental health care company reported a larger-than-anticipated loss, disappointing investors and triggering a sell-off.\nAccording to the earnings report, Compass Pathways posted a quarterly adjusted loss of $1.44 per share for the quarter ended September 30, significantly wider than the loss of $0.56 per share reported in the same quarter last year. This figure also surpassed the mean expectation of ten analysts, who had forecast a loss of $0.39 per share. The company's reported loss of $137.72 million for the quarter further underscored the financial challenges it faces.\nDespite the negative financial results, Compass Pathways remains focused on advancing its research in mental health treatments. The company announced plans to speed up the launch of its depression drug, which could potentially offer a new avenue for growth. However, investors seemed more concerned with the immediate financial performance, leading to the sharp decline in stock price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153232989","isCrawlerRequest":true}